MEF2C expression was also significantly higher in AML than control subjects, (median 5.2, range 0.8–54.5 versus 1, range 0.29–2.5; p = 0.007) (Table 2; Fig. 1). The gene discussed is MEF2C; the disease is acute myeloid leukemia.